BioImagene Inc. to Present at Medtech Insight and Windhover Information's ``Investment In Innovation (In3) WEST'' Conference, February 23-24, 2006, Irvine, CA.

IRVINE, Calif. -- BioImagene Inc. has announced that it will be presenting on 23rd Feb. '06 at Medtech Insight and Windhover Information's "Investment In Innovation (In3) WEST: A Preview of Early-Stage Medical Technology Companies" Conference, Feb. 23-24, 2006, at the Hyatt Regency Irvine in Irvine, Calif.

BioImagene Inc. is a leading company pioneering a new generation of image informatics solutions targeted to the specific needs of the life science research and medical diagnostic workspace. BioImagene provides sophisticated Bio-Image Analysis & Management products built on the technology platforms SIMS(TM) & iHarness(TM). BioImagene's products allow pathologists to effectively analyze and manage tissue image data. These web-based automated informatics tools provide consistent, reproducible and objective analysis of tissue images, while support storage, retrieval and data sharing for peer review, improving the standard of patient care and increasing the speed of drug discovery.

Tissue analysis forms the core component of the drug development cycles, from target identification, lead validation and clinical trials to Tox-Path screenings and disease diagnosis. More than 70% of the pathological data is in form of tissue images. Despite the technological advancements, the pathological evaluation of thousands of tissues samples still remains very manual: pathologists still spend hundreds of hours looking at a glass slide to make a diagnosis. A huge increase in the drug candidates entering development and the specimens for evaluation has led to a growing need for a comprehensive approach to pathology evaluation called 'Digital Pathology.'

TissueMine(TM), a tissue-informatics application from BioImagene, caters to the industry bottlenecks by facilitating automation and standardization of evaluation of histopathological tissue specimen images, assisting pathologists to direct their efforts on more challenging areas of abnormalities. Its self-learning engine analyzes image using color, intensity, and morphological patterns. The web-based architecture helps the community to share the information in a more effective way and for cost-efficient statistical analysis. Twelve of the world's leading pharmaceuticals are successfully using our solutions. The application can analyze the slides of tissue sections stained for various biomarkers, and can store and manage this image data for peer review and consultation. Importantly, these systems are also hardware independent, and can be customized as per the existing workflow.

At BioImagene we believe that Digital Pathology is the next big frontier of unexplored opportunities in an untapped market, and we are well positioned to lead that wave with focus on "Pathology Imaging."

A division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. In3 WEST is Medtech Insight's 20th investment and partnering event to date. To register to attend or for more information on Medtech Insight, please call Kristy Grimes at 480-985-9512 or 888-202-5939 toll-free in the U.S., e-mail [e-mail], or visit www.medtechinsight.com.